Project Grant HT94252410234
Award Date
7/1/24
Completion Date
6/30/27
Dollars Obligated
$488K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Tacoma, WA 98402, USA
Similar Awards
The Department of the Army's Military Medical Research and Development program (CFDA 12.420) awarded a $1,009,750 Project Grant to The Geneva Foundation, a non-profit research organization based in Tacoma, Washington. This 3-year grant, awarded on August 1, 2025, will support advanced biomedical research to characterize the genetic and functional basis of chemoresistance in small cell lung cancer. The research aims to transform healthcare for military service members and the broader public by...
The Geneva Foundation was awarded a $1,597,740 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 2022 to June 2026 to develop new methods for accessing extracellular vesicle MDM2 DNA cargo as a potential liposarcoma biomarker. Through support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform...
The Department of the Army Medical Command awarded The Geneva Foundation a $909,510 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research focused on precision therapy for the eradication of brain metastatic breast cancer. The project, which runs from May 1, 2025 to April 30, 2028, will leverage The Geneva Foundation's expertise in biomedical research, clinical studies, and innovative medical...
This Project Grant award for $366,000.00, awarded on Sep 30, 2024 by the Defense Health Agency, supports research conducted by The Geneva Foundation to identify functional structural variants that influence therapy outcomes for human castration-resistant prostate cancer. The award is funded through the Military Medical Research and Development program (CFDA 12.420), which supports a broad range of biomedical research initiatives to improve health outcomes for military service members,...
The Department of the Army awarded a $6,663,794 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Geneva Foundation, a non-profit medical research organization based in Tacoma, Washington. The grant, titled "PRECISIE RTD TRIAL: PRECISION WITH RETURN-TO-DUTY DECISIONS IN THE MILITARY", will fund advanced biomedical research focused on improving return-to-duty decisions for military personnel. The Geneva Foundation will collaborate with a...
The Geneva Foundation received a $453,029 Project Grant award from the Department of the Army Medical Command on February 1, 2021 to improve the therapeutic index of antibody drug conjugates targeting metastatic breast cancer. Funded through January 31, 2024 under the Military Medical Research and Development program (CFDA 12.420), this award will support the Foundation's work to transform healthcare and investigate medical solutions for the battlefield by developing more effective targeted...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $573,416 project grant to The Geneva Foundation to conduct a study titled "PRE-DIAGNOSTIC SERUM CONCENTRATIONS OF PER- AND POLYFLUOROALKYL SUBSTANCES AND RISK OF TESTICULAR GERM CELL TUMORS AMONG ACTIVE-DUTY SERVICEMEN." The 3-year grant, which began on Sep 30, 2023, will support research investigating the relationship between exposure to per- and polyfluoroalkyl substances...
The Defense Health Agency awarded a $325,650 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Geneva Foundation, a non-profit organization based in Tacoma, Washington. The grant, titled "Assessment of Changes in Human Blood Proteome Following Total Sleep Deprivation," will fund research to advance understanding of the impact of sleep deprivation on the human blood proteome over a 2-year period from March 1, 2025, to February 28, 2027. The...
The Geneva Foundation was awarded a $362,100 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program to conduct research toward the dual targeting of HER2 and androgen receptor in patients with high-risk, hormone-naive prostate cancer with curative intent. The two-year grant project period runs from June 1, 2022 to May 31, 2024. Through this funding, The Geneva Foundation will perform applied medical research investigating...
The Defense Health Agency awarded a $410,000 Project Grant titled "Localized and Inflammation-Responsive Immunotherapy of VCA Rejection" to The Geneva Foundation, a 501(c)3 non-profit organization that supports medical research and education for the U.S. military. This grant is part of the "Military Medical Research and Development" program (CFDA 12.420), which funds basic, applied, and advanced biomedical research to transform healthcare for Service Members and the public...